In particular, the epigenetic silencing of the CDKN2A locus, a well-known driver mutation in asbestos-induced mesothelioma, has been documented in mice exposed to commercial long MWCNTs together with the loss of p16 and p19 protein expression [38]. Here, CDKN2A is linked to mesothelioma.